Transamerica Financial Advisors, Inc. Eli Lilly & CO Transaction History

Transamerica Financial Advisors, Inc.

$1.02 Billion
Q3 2024

A detailed history of Transamerica Financial Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Transamerica Financial Advisors, Inc. holds 7,535 shares of LLY stock, worth $6.11 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

7,535

Previous 9,295 18.93%

Holding current value

$6.11 Million

Previous $8.42 Million 20.69%

% of portfolio

0.65%

Previous 0.9%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $1.36 Million - $1.69 Million	-1,760 Reduced 18.93%	7,535 $6.68 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $3.95 Million - $5.28 Million	6,668 Added 253.83%	9,295 $7.23 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $727,913 - $858,114	1,386 Added 111.68%	2,627 $1.53 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $869 - $1,198	2 Added 0.16%	1,241 $667,000
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $425,096 - $568,403	1,212 Added 4488.89%	1,239 $581,000
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $929,715 - $1.09 Million	-2,993 Reduced 99.11%	27 $9,000
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $23,151 - $26,976	72 Added 2.44%	3,020 $1.11 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $106,732 - $121,633	360 Added 13.91%	2,948 $954,000
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $720,517 - $845,992	2,585 Added 86166.67%	2,588 $839,000
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $221 - $272	-1 Reduced 25.0%	3 $1,000
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $1,986 - $2,568	-11 Reduced 73.33%	4 $1,000
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $164 - $212	1 Added 7.14%	15 $3,000
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $1.6 Million - $1.85 Million	-10,928 Reduced 99.87%	14 $2,000
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $1.49 Million - $1.79 Million	10,931 Added 99372.73%	10,942 $1.8 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $119 - $147	-1 Reduced 8.33%	11 $2,000
Q4 2019 Feb 05, 2020	BUY	$106.92 - $132.43 $213 - $264	2 Added 20.0%	12 $2,000
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $661,136 - $719,146	-6,191 Reduced 99.84%	10 $2,000
Q2 2019 Aug 21, 2019	BUY	$110.79 - $129.32 $686,122 - $800,878	6,193 Added 77412.5%	6,201 $687,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $487,871 - $574,260	-4,383 Reduced 99.82%	8 $1,000
Q4 2018 Feb 04, 2019	SELL	$105.9 - $118.64 $112,465 - $125,995	-1,062 Reduced 19.48%	4,391 $509,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $18,545 - $23,178	216 Added 4.12%	5,453 $586,000
Q2 2018 Jul 25, 2018	BUY	$75.7 - $86.88 $395,532 - $453,948	5,225 Added 43541.67%	5,237 $447,000
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $491 - $527	-6 Reduced 33.33%	12 $1,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $1,387 - $1,539	18	18 $2,000

Others Institutions Holding LLY

# of Institutions

4,073

Shares Held

737M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $771B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transamerica Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Transamerica Financial Advisors, Inc. with notifications on news.

Account

Transamerica Financial Advisors, Inc. Eli Lilly & CO Transaction History